Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 109Leukemia 21Recurrence 12Myelodysplastic Syndromes 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Neoplasms 5Leukemia, Myeloid 5Hematologic Neoplasms 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Lymphoma 3Leukemia, Biphenotypic, Acute 3Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Leukemia, Myelomonocytic, Chronic 2Hematologic Diseases 2Congenital Abnormalities 2Thrombocytopenia 1Sarcoma, Myeloid 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) 1Pathologic Complete Response 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms by Histologic Type 1Neoplasm, Residual 1Neoplasm Metastasis 1Myeloid Malignancies 1Meningitis 1Meningeal Neoplasms 1Lymphoma, Mantle-Cell 1

Interventions

Vaccines 1Papillomavirus Vaccines 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Meningitis × Cytarabine × Clear all
NCT00029523 2007-02-28

DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor

Pacira Pharmaceuticals, Inc

Phase 4 Completed
100 enrolled

Meningeal Neoplasms, Meningitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡